Ozempic is a medication initially approved for managing type 2 diabetes but has gained popularity as a weight loss treatment for individuals who meet certain criteria
Specifically, the GLP-1 hormone lowers blood glucose levels by prompting the expansion of insulin-secreting -cell mass, a type of cell that makes and secretes insulin, in your pancreas
Weight regain following GLP-1 withdrawal: Systematic review and meta-analysis
Its approved by the FDA to help with long-term weight management and treating type 2 diabetes
While current methods of diagnosing SCC are highly effective, they are invasive and cannot easily monitor metabolic changes within tumors
doi: 10.3389/fphar.2020.00805 Received 26 February 2020 Accepted 18 May 2020 Published 29 May 2020 Volume 11 - 2020 Edited by Nicolau Beckmann, Novartis Institutes for BioMedical Research, Switzerland Reviewed by Jonathan Kirk, Loyola University Chicago, United States